New offering expands company’s imaging services into whole-body MRI and preventive care.
SimonMed has introduced SimonMed Longevity, a new division focused on artificial intelligence (AI)-enabled preventive care and longevity screening, alongside an updated brand positioning.
The launch marks an expansion of SimonMed’s approach to patient care, adding earlier risk identification and preventive support to its existing diagnostic imaging services through the use of artificial intelligence.
SimonMed Longevity will offer whole-body MRI and enhanced, multi-modality screening aimed at individuals seeking a more proactive approach to health and long-term wellbeing. The company plans to initially offer longevity services at 30 locations nationwide, with availability expected to expand to more than 70 sites by the end of the first quarter of 2026.
“For more than 20 years, SimonMed has focused on helping people get affordable access to the most advanced imaging technology,” says Dr John Simon, founder and CEO, in a release. “Today, those same technologies allow us not only to diagnose and treat disease earlier, but to identify risk sooner and help patients prevent, or delay onset, of many conditions.”
SimonMed Longevity will provide a tiered portfolio of preventive MRI screening packages powered by 3T MRI technology, AI-enabled imaging protocols, and interpretation by the company’s nationwide team of board-certified radiologists.
The new division builds on the company’s existing simonONE whole-body MRI program. Following patient adoption and demand for proactive screening, SimonMed is integrating those offerings into the core brand. During a transition period, simonONE will remain available at select locations.
“Bringing Longevity under SimonMed allows us to scale preventive care more effectively and deliver a more seamless experience for patients and providers,” says. Simon in a release. “Preventive imaging shouldn’t be a standalone offering—it should be part of routine healthcare.”
The company says the launch of SimonMed Longevity reflects its next phase of growth, with a focus on earlier access to advanced imaging and preventive insights.
“This evolution isn’t about changing who we are,” says Jenna Lloyd, chief marketing officer at SimonMed, in a release. “It’s about building on our expertise in response to what patients are asking for—a clearer understanding of their health, and what to do about it, so they can live healthier, longer lives.”
ID 8159311 © Krishnacreations | Dreamstime.com
